DOD Biotech PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	608.98	645.38	663.61	537.16	1,015
Other Revenue	12.23	16.65	29.09	11.17	3.03
Revenue	621.21	662.04	692.71	548.33	1,018
Revenue Growth (YoY)	-6.17%	-4.43%	26.33%	-46.16%	-5.70%
Cost of Revenue	398.92	438.58	406.36	396.66	580.7
Gross Profit	222.3	223.46	286.35	151.68	437.65
Selling, General & Admin	182.98	209	198.52	163.05	126.84
Operating Expenses	182.98	209	198.52	163.05	128.35
Operating Income	39.32	14.46	87.84	-11.38	309.3
Interest Expense	-2.86	-3.73	-5.31	-7.09	-6.72
Interest & Investment Income	2.01	0.73	0.25	0.11	0.25
EBT Excluding Unusual Items	38.46	11.46	82.78	-18.36	302.84
Gain (Loss) on Sale of Investments	4.98	29.03	10.04	-405.86	15.45
Asset Writedown	-	-	-	-	-53.23
Pretax Income	43.45	40.49	92.82	-424.23	265.06
Income Tax Expense	-6.65	13.32	28.3	-79.11	31.96
Earnings From Continuing Operations	50.1	27.17	64.51	-345.12	233.1
Earnings From Discontinued Operations	11.67	-190.99	-50.94	-55.37	-187.44
Net Income to Company	61.77	-163.82	13.57	-400.49	45.66
Minority Interest in Earnings	-2.18	4.48	-6.39	2.15	4.12
Net Income	59.59	-159.33	7.19	-398.33	49.79
Net Income to Common	59.59	-159.33	7.19	-398.33	49.79
Net Income Growth	-	-	-	-	-64.75%
Shares Outstanding (Basic)	450	450	435	410	410
Shares Outstanding (Diluted)	450	450	435	410	410
Shares Change (YoY)	-	3.47%	6.17%	-	-
EPS (Basic)	0.13	-0.35	0.02	-0.97	0.12
EPS (Diluted)	0.13	-0.35	0.02	-0.97	0.12
EPS Growth	-	-	-	-	-64.45%
Free Cash Flow	42.43	12.31	4.72	-194	-37.93
Free Cash Flow Per Share	0.09	0.03	0.01	-0.47	-0.09
Dividend Per Share	0.050	-	-	-	-
Gross Margin	35.78%	33.75%	41.34%	27.66%	42.98%
Operating Margin	6.33%	2.18%	12.68%	-2.08%	30.37%
Profit Margin	9.59%	-24.07%	1.04%	-72.65%	4.89%
Free Cash Flow Margin	6.83%	1.86%	0.68%	-35.38%	-3.72%
EBITDA	80.42	71.39	156.11	48.03	371.45
EBITDA Margin	12.95%	10.78%	22.54%	8.76%	36.48%
D&A For EBITDA	41.1	56.93	68.27	59.41	62.15
EBIT	39.32	14.46	87.84	-11.38	309.3
EBIT Margin	6.33%	2.18%	12.68%	-2.08%	30.37%
Effective Tax Rate	-	32.89%	30.49%	-	12.06%
Revenue as Reported	621.21	662.04	692.71	548.33	1,018

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.